Praxis Precision Medicines Inc (PRAX)
44.08
+1.37
(+3.21%)
USD |
NASDAQ |
May 24, 16:00
43.77
-0.31
(-0.70%)
After-Hours: 20:00
Praxis Precision Medicines Shareholders Equity (Quarterly): 229.68M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 229.68M |
| December 31, 2023 | 69.67M |
| September 30, 2023 | 86.76M |
| June 30, 2023 | 105.62M |
| March 31, 2023 | 64.47M |
| December 31, 2022 | 76.11M |
| September 30, 2022 | 105.16M |
| June 30, 2022 | 138.87M |
| March 31, 2022 | 191.02M |
| Date | Value |
|---|---|
| December 31, 2021 | 250.81M |
| September 30, 2021 | 295.92M |
| June 30, 2021 | 333.77M |
| March 31, 2021 | 265.52M |
| December 31, 2020 | 287.46M |
| September 30, 2020 | 108.97M |
| June 30, 2020 | 14.11M |
| December 31, 2019 | 40.11M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
14.11M
Minimum
Jun 2020
333.77M
Maximum
Jun 2021
156.71M
Average
108.97M
Median
Sep 2020
Shareholders Equity (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 561.41M |
| Regeneron Pharmaceuticals Inc | 26.99B |
| Atossa Therapeutics Inc | 85.76M |
| ADMA Biologics Inc | 153.71M |
| Viking Therapeutics Inc | 933.89M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 250.41M |
| Total Liabilities (Quarterly) | 20.73M |
| Current Ratio | 11.27 |